BTB/POZ domain-containing protein KCTD20 (KCTD20, C6orf69)
Jump to navigation
Jump to search
Function
- component of a complex containing MARK4
- promotes phosphorylation of AKT family members[1]
- suppresses or inhibits lysosomes[1]
Structure
contains 1 BTB domain (POZ domain)
Alternative splicing
named isoforms=2
Pathology
More general terms
References
- ↑ 1.0 1.1 1.2 UniProt http://www.uniprot.org/uniprot/Q7Z5Y7.html
- ↑ Berlind JE, Lai JD, Lie C et al KCTD20 suppression mitigates excitotoxicity in tauopathy patient organoids. Neuron March 5, 2025 PMID: https://www.ncbi.nlm.nih.gov/pubmed/40049159 https://www.cell.com/neuron/abstract/S0896-6273(25)00114-X
- ↑ 3.0 3.1 Nawa M, Matsuoka M. KCTD20, a relative of BTBD10, is a positive regulator of Akt. BMC Biochem. 2013 Oct 24;14:27. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24156551 PMCID: PMC3827329 Free PMC article
- ↑ Zhang X, Zhou H, Cai L, Fan C, Liu Y, Wang L, Li Q, Miao Y. Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients. Mol Carcinog. 2017 Sep;56(9):2058-2065. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28398603